Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details 2)

v3.24.2.u1
Stockholders' Equity (Details 2) - Restricted Stock Units (RSUs) [Member] - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of options outstanding at beginning of period 67,250  
Weighted average exercise price at beginning of period $ 2.25  
Weighted average remaining life (years) 2 years 3 months 29 days 2 years 25 days
Aggregate intrinsic value at beginning of period $ 36,651  
Number of options, Granted 87,300  
Weighted average grant - date fair value price, Granted $ 0.84  
Aggregate intrinsic value Granted $ 47,579  
Number of options, Exercised 0  
Weighted average exercise price, Exercised $ 0  
Aggregate intrinsic value Exercised $ 0  
Number of options, Forfeited/canceled (23,337)  
Weighted average exercise price, Forfeited/canceled $ (1.60)  
Aggregate intrinsic value Forfeited/canceled $ (12,719)  
Number of options outstanding at ending of period 131,213 67,250
Weighted average exercise price at ending of period $ 1.43 $ 2.25
Aggregate intrinsic value at ending of period $ 71,511 $ 36,651